{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T12:17:53Z","timestamp":1791980273988,"version":"4.4.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":4303,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1038\/modpathol.2010.224","type":"journal-article","created":{"date-parts":[[2010,12,24]],"date-time":"2010-12-24T10:18:22Z","timestamp":1293185902000},"page":"585-595","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":137,"title":["Aberrant expression of CD30 in neoplastic mast cells in high-grade mastocytosis"],"prefix":"10.1016","volume":"24","author":[{"given":"Karl","family":"Sotlar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Cerny-Reiterer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina","family":"Petat-Dutter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Hessel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabina","family":"Berezowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonhard","family":"M\u00fcllauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Valent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Peter","family":"Horny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/modpathol.2010.224_bib1","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1365-2559.1979.tb03017.x","article-title":"Mast cells and mast cell neoplasia: a review","volume":"3","author":"Lennert","year":"1979","journal-title":"Histopathology"},{"key":"10.1038\/modpathol.2010.224_bib2","doi-asserted-by":"crossref","first-page":"2S","DOI":"10.1111\/1523-1747.ep12468882","article-title":"Classification and diagnosis of mastocytosis: current status","volume":"96","author":"Metcalfe","year":"1991","journal-title":"J Invest Dermatol"},{"key":"10.1038\/modpathol.2010.224_bib3","first-page":"385","article-title":"Biology, classification and treatment of human mastocytosis","volume":"108","author":"Valent","year":"1996","journal-title":"Wien Klin Wochenschr"},{"key":"10.1038\/modpathol.2010.224_bib4","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0145-2126(01)00038-8","article-title":"Diagnostic criteria and classification of mastocytosis: a consensus proposal","volume":"25","author":"Valent","year":"2001","journal-title":"Leuk Res"},{"key":"10.1038\/modpathol.2010.224_bib5","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1146\/annurev.med.55.091902.103822","article-title":"Systemic mastocytosis","volume":"55","author":"Akin","year":"2004","journal-title":"Annu Rev Med"},{"key":"10.1038\/modpathol.2010.224_bib6","series-title":"WHO Classification of Tumours. Tumours of Haematopoietic and Lymphoid Tissues","first-page":"291","article-title":"Mastocytosis (mast cell disease)","author":"Valent","year":"2001"},{"key":"10.1038\/modpathol.2010.224_bib7","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","first-page":"54","article-title":"Mastocytosis (mast cell disease)","author":"Horny","year":"2008"},{"key":"10.1038\/modpathol.2010.224_bib8","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1046\/j.1365-2141.2003.04575.x","article-title":"Diagnosis and treatment of systemic mastocytosis: state of the art","volume":"122","author":"Valent","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1038\/modpathol.2010.224_bib9","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.jaci.2009.05.003","article-title":"Prognosis in adult indolent systemic mastocytosis: a long-term study of the Spanish network on mastocytosis in a series of 145 patients","volume":"124","author":"Escribano","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1038\/modpathol.2010.224_bib10","doi-asserted-by":"crossref","first-page":"5727","DOI":"10.1182\/blood-2009-02-205237","article-title":"Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors","volume":"113","author":"Lim","year":"2009","journal-title":"Blood"},{"key":"10.1038\/modpathol.2010.224_bib11","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1365-2362.2007.01807.x","article-title":"Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria","volume":"37","author":"Valent","year":"2007","journal-title":"Eur J Clin Invest"},{"issue":"Suppl 2","key":"10.1038\/modpathol.2010.224_bib12","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.0960-135X.2004.01369.x","article-title":"On the way to targeted therapy of mast cell neoplasms: identification of molecular targets in neoplastic mast cells and evaluation of arising treatment concepts","volume":"34","author":"Valent","year":"2004","journal-title":"Eur J Clin Invest"},{"key":"10.1038\/modpathol.2010.224_bib13","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/00062752-200401000-00009","article-title":"Clinical, genetic, and therapeutic insights into systemic mast cell disease","volume":"11","author":"Tefferi","year":"2004","journal-title":"Curr Opin Hematol"},{"key":"10.1038\/modpathol.2010.224_bib14","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.beha.2005.07.010","article-title":"Pathogenesis, clinical features, and treatment advances in mastocytosis","volume":"19","author":"Pardanani","year":"2006","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1038\/modpathol.2010.224_bib15","doi-asserted-by":"crossref","first-page":"10560","DOI":"10.1073\/pnas.92.23.10560","article-title":"Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder","volume":"92","author":"Nagata","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/modpathol.2010.224_bib16","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/ng0396-312","article-title":"Somatic c-KIT activating mutation in urticaria pigmentosa and aggressive mastocytosis: establishment of clonality in a human mast cell neoplasm","volume":"12","author":"Longley","year":"1996","journal-title":"Nat Genet"},{"key":"10.1038\/modpathol.2010.224_bib17","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1073\/pnas.96.4.1609","article-title":"Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis","volume":"96","author":"Longley","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/modpathol.2010.224_bib18","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1046\/j.1365-2141.2001.02783.x","article-title":"Mutation analysis of C-KIT in patients with myelodysplastic syndromes without mastocytosis and cases of systemic mastocytosis","volume":"113","author":"Fritsche-Polanz","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1038\/modpathol.2010.224_bib19","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1159\/000048179","article-title":"Kit and c-kit mutations in mastocytosis: a short overview with special reference to novel molecular and diagnostic concepts","volume":"127","author":"Feger","year":"2002","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1038\/modpathol.2010.224_bib20","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1182\/blood-2006-04-015545","article-title":"KIT mutation in mast cells and other bone marrow hematopoietic cell lineages in systemic mast cell disorders: a prospective study of the Spanish network on mastocytosis (REMA) in a series of 113 patients","volume":"108","author":"Garcia-Montero","year":"2006","journal-title":"Blood"},{"key":"10.1038\/modpathol.2010.224_bib21","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1172\/JCI116761","article-title":"Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product","volume":"92","author":"Furitsu","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1038\/modpathol.2010.224_bib22","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1155\/1998\/341340","article-title":"Immunophenotypic characterization of human bone marrow mast cells. A flow cytometric study of normal and pathological bone marrow samples","volume":"16","author":"Escribano","year":"1998","journal-title":"Anal Cell Pathol"},{"key":"10.1038\/modpathol.2010.224_bib23","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0145-2126(01)00050-9","article-title":"Utility of flow cytometric analysis of mast cells in the diagnosis and classification of adult mastocytosis","volume":"25","author":"Escribano","year":"2001","journal-title":"Leuk Res"},{"key":"10.1038\/modpathol.2010.224_bib24","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1097\/01.pas.0000138181.89743.7b","article-title":"CD25 indicates the neoplastic phenotype of mast cells: a novel immunohistochemical marker for the diagnosis of systemic mastocytosis (SM) in routinely processed bone marrow biopsy specimens","volume":"28","author":"Sotlar","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2010.224_bib25","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1097\/00000478-199809000-00013","article-title":"Diagnostic value of immunostaining for tryptase in patients with mastocytosis","volume":"22","author":"Horny","year":"1998","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2010.224_bib26","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0145-2126(01)00019-4","article-title":"A case of \u2018smouldering\u2019 mastocytosis with high mast cell burden, monoclonal myeloid cells, and C-KIT mutation Asp-816-Val","volume":"25","author":"Jordan","year":"2001","journal-title":"Leuk Res"},{"key":"10.1038\/modpathol.2010.224_bib27","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.2353\/ajpath.2009.080953","article-title":"Expression of activated STAT5 in neoplastic mast cells in systemic mastocytosis: subcellular distribution and role of the transforming oncoprotein KIT D816V","volume":"175","author":"Baumgartner","year":"2009","journal-title":"Am J Pathol"},{"key":"10.1038\/modpathol.2010.224_bib28","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jaci.2009.10.020","article-title":"Mast cells from different molecular and prognostic subtypes of systemic mastocytosis display distinct immunophenotypes","volume":"125","author":"Teodosio","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1038\/modpathol.2010.224_bib29","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/299065a0","article-title":"Production of a monoclonal antibody specific for Hodgkin and Sternberg-Reed cells of Hodgkin\u2032s disease and a subset of normal lymphoid cells","volume":"299","author":"Schwab","year":"1982","journal-title":"Nature"},{"key":"10.1038\/modpathol.2010.224_bib30","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1182\/blood.V66.4.848.848","article-title":"The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells","volume":"66","author":"Stein","year":"1985","journal-title":"Blood"},{"key":"10.1038\/modpathol.2010.224_bib31","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1006\/clim.1998.4636","article-title":"CD30 in normal and neoplastic cells","volume":"90","author":"Chiarle","year":"1999","journal-title":"Clin Immunol"},{"key":"10.1038\/modpathol.2010.224_bib32","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/sj.leu.2404491","article-title":"Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients","volume":"21","author":"Pileri","year":"2007","journal-title":"Leukemia"},{"key":"10.1038\/modpathol.2010.224_bib33","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1093\/ajcp\/102.3.292","article-title":"CD30 antigen expression in florid immunoblastic proliferations. A clinicopathologic study of 14 cases","volume":"102","author":"Segal","year":"1994","journal-title":"Am J Clin Pathol"},{"key":"10.1038\/modpathol.2010.224_bib34","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1177\/29.4.6166661","article-title":"Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures","volume":"29","author":"Hsu","year":"1981","journal-title":"J Histochem Cytochem"},{"key":"10.1038\/modpathol.2010.224_bib35","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0022-1759(99)00240-9","article-title":"Automated data acquisition by confocal laser scanning microscopy and image analysis of triple stained immunofluorescent leukocytes in tissue","volume":"237","author":"Steiner","year":"2000","journal-title":"J Immunol Methods"},{"key":"10.1038\/modpathol.2010.224_bib36","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1182\/blood-2007-09-115477","article-title":"Oncogenic kit controls neoplastic mast cell growth through a Stat5\/PI3-kinase signaling cascade","volume":"112","author":"Harir","year":"2008","journal-title":"Blood"},{"key":"10.1038\/modpathol.2010.224_bib37","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S0002-9440(10)63870-9","article-title":"One-step detection of c-kit point mutations using peptide nucleic acid-mediated polymerase chain reaction clamping and hybridization probes","volume":"162","author":"Sotlar","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1038\/modpathol.2010.224_bib38","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1002\/path.2677","article-title":"Variable presence of KIT(D816V) in clonal haematological non-mast cell lineage diseases associated with systemic mastocytosis (SM-AHNMD)","volume":"220","author":"Sotlar","year":"2009","journal-title":"J Pathol"},{"key":"10.1038\/modpathol.2010.224_bib39","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1002\/jlb.58.6.683","article-title":"Not only Th2 cells but also Th1 and Th0 cells express CD30 after activation","volume":"58","author":"Bengtsson","year":"1995","journal-title":"J Leukoc Biol"},{"key":"10.1038\/modpathol.2010.224_bib40","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1365-2559.1990.tb01151.x","article-title":"The diagnostic significance of the CD30 (Ki-1) antigen","volume":"16","author":"Pallesen","year":"1990","journal-title":"Histopathology"},{"key":"10.1038\/modpathol.2010.224_bib41","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/0092-8674(93)90361-S","article-title":"CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF","volume":"73","author":"Smith","year":"1993","journal-title":"Cell"},{"key":"10.1038\/modpathol.2010.224_bib42","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/0952-7915(94)90119-8","article-title":"Tumor necrosis factor receptor superfamily members and their ligands","volume":"6","author":"Armitage","year":"1994","journal-title":"Curr Opin Immunol"},{"key":"10.1038\/modpathol.2010.224_bib43","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1182\/blood.V89.6.2048","article-title":"CD30 ligand is frequently expressed in human hematopoietic malignancies of myeloid and lymphoid origin","volume":"89","author":"Gattei","year":"1997","journal-title":"Blood"},{"key":"10.1038\/modpathol.2010.224_bib44","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1046\/j.1365-2141.2001.02977.x","article-title":"Mast cells express functional CD30 ligand and are the predominant CD30L-positive cells in Hodgkin's disease","volume":"114","author":"Molin","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1038\/modpathol.2010.224_bib45","first-page":"469","article-title":"CD30 ligand expression in nonmalignant and Hodgkin's disease-involved lymphoid tissues","volume":"149","author":"Gruss","year":"1996","journal-title":"Am J Pathol"},{"key":"10.1038\/modpathol.2010.224_bib46","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1038\/labinvest.3780117","article-title":"Autocrine growth regulation of CD30 ligand in CD30-expressing Reed-Sternberg cells: distinction between Hodgkin's disease and anaplastic large cell lymphoma","volume":"80","author":"Hsu","year":"2000","journal-title":"Lab Invest"},{"key":"10.1038\/modpathol.2010.224_bib47","doi-asserted-by":"crossref","first-page":"510","DOI":"10.2353\/ajpath.2008.070858","article-title":"CD30-induced signaling is absent in Hodgkin's cells but present in anaplastic large cell lymphoma cells","volume":"172","author":"Hirsch","year":"2008","journal-title":"Am J Pathol"},{"key":"10.1038\/modpathol.2010.224_bib48","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/eji.1830190125","article-title":"Ki-1 (CD30) antigen is released by Ki-1-positive tumor cells in vitroin vivo. I. Partial characterization of soluble Ki-1 antigen and detection of the antigen in cell culture supernatants and in serum by an enzyme-linked immunosorbent assay","volume":"19","author":"Josimovic-Alasevic","year":"1989","journal-title":"Eur J Immunol"},{"key":"10.1038\/modpathol.2010.224_bib49","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1182\/blood.V91.8.3011.3011_3011_3016","article-title":"Serum level of the soluble form of the CD30molecule identifies patients with Hodgkin's disease at high risk of unfavorable outcome","volume":"91","author":"Nadali","year":"1998","journal-title":"Blood"},{"key":"10.1038\/modpathol.2010.224_bib50","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1200\/JCO.1998.16.4.1532","article-title":"Clinical implications of serum levels of soluble CD30 in 70 adult anaplastic large-cell lymphoma patients","volume":"16","author":"Zinzani","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1038\/modpathol.2010.224_bib51","doi-asserted-by":"crossref","first-page":"110","DOI":"10.2174\/138945009787354566","article-title":"Anti-CD30 human IL-2 fusion proteins display strong and specific cytotoxicity in vivo","volume":"10","author":"Hirsch","year":"2009","journal-title":"Curr Drug Targets"},{"key":"10.1038\/modpathol.2010.224_bib52","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2141.2009.07740.x","article-title":"A Phase II study of SGN-30 (anti-CD30mAb) in Hodgkin lymphoma or systemic anaplastic large cell lymphoma","volume":"146","author":"Forero-Torres","year":"2009","journal-title":"Br J Haematol"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/modpathol2010224.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol2010224","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222028939?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222028939?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol2010224.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T01:05:26Z","timestamp":1760231126000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222028939"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":52,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["S0893395222028939"],"URL":"https:\/\/doi.org\/10.1038\/modpathol.2010.224","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aberrant expression of CD30 in neoplastic mast cells in high-grade mastocytosis","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/modpathol.2010.224","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2011 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}